Skip to Main Content

Paper Details

Timing and Reporting of Secondary Overall Survival End Points for Phase III Trials in Advanced/Metastatic Disease.
J Clin Oncol
0
2023
Author NameAffiliation
Larissa A KordeNational Cancer Institute
  • 1 - 1

Datasets

Release 1.2